Telmisartan

Buy Telmisartan Online

Telmisartan is an angiotensin II receptor blocker (ARB) used clinically to treat hypertension and, in appropriate patients, reduce cardiovascular risk. It has also been investigated for metabolic and PPAR-related effects beyond conventional blood-pressure control.

Product Information

Telmisartan selectively blocks the angiotensin II AT1 receptor, preventing angiotensin II from producing vasoconstriction and aldosterone-related effects. It has a long elimination half-life, supporting once-daily administration in standard clinical use.

How It Works

Telmisartan blocks AT1 receptors in the renin-angiotensin system. This reduces vasoconstriction and aldosterone-mediated sodium retention, lowering vascular resistance and blood pressure.

POTENTIAL BENEFITS

1. Blood-Pressure Research

Telmisartan is well established as an antihypertensive medication. Controlled clinical studies have demonstrated reductions in blood pressure through blockade of angiotensin II signaling.

2. Cardiovascular Research

By reducing blood pressure and blocking AT1 signaling, telmisartan has been studied extensively in cardiovascular-risk populations. Its clinical research extends beyond simple blood-pressure measurements.

3. Renin-Angiotensin Research

Telmisartan is an important pharmacological tool for studying the renin-angiotensin-aldosterone system. AT1 receptor blockade allows researchers to examine downstream cardiovascular and renal effects of angiotensin II.

4. Metabolic Research

Telmisartan has also attracted interest because of reported interactions with metabolic pathways, including partial PPAR-γ activity. These effects have been investigated separately from its established ARB mechanism.

Dosage

For hypertension, the current U.S. labeling lists 40 mg once daily as the usual starting dose, with a usual range of 40–80 mg once daily. For cardiovascular-risk reduction in the labeled indication, 80 mg once daily is specified. Dosage must be individualized according to indication and clinical response.

Side Effects

Common concerns include dizziness, hypotension, and changes in kidney function or potassium levels. Telmisartan carries an important pregnancy warning because drugs acting on the renin-angiotensin system can cause fetal injury.

References

1. DailyMed — current Telmisartan prescribing information
2. DailyMed — Telmisartan label and warnings
3. Telmisartan cardiovascular outcomes research — PubMed
4. Telmisartan and PPAR-gamma research — PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.